Cargando…
Renal biopsy: it is time for pragmatism and consensus
To obtain truly informed consent, we must be able to advise our patients accurately about the relative risk and benefit of any treatment plan. Percutaneous renal biopsy remains the gold standard investigation in the evaluation of intrinsic renal disease. There have been significant improvements in p...
Autores principales: | Lees, Jennifer S, McQuarrie, Emily P, Mackinnon, Bruce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165764/ https://www.ncbi.nlm.nih.gov/pubmed/30289128 http://dx.doi.org/10.1093/ckj/sfy075 |
Ejemplares similares
-
Risk of percutaneous renal biopsy of native kidneys in the evaluation of acute kidney injury
por: Korbet, Stephen M, et al.
Publicado: (2018) -
Comparison of native and transplant kidney biopsies: diagnostic yield and complications
por: Whittier, William L, et al.
Publicado: (2018) -
Risk factors for bleeding complications after nephrologist-performed native renal biopsy
por: Lees, Jennifer S., et al.
Publicado: (2017) -
Haemodynamic or metabolic stimulation tests to reveal the renal functional response: requiem or revival?
por: De Moor, Bart, et al.
Publicado: (2018) -
Testing for COVID-19: a 2023 update
por: Meumann, Ella M, et al.
Publicado: (2023)